Availability and accessibility of monoclonal antibodies in Bosnia and Herzegovina: Findings and implications
Background: Monoclonal antibodies (mAbs) represent the most numerous and significant group of biotherapeutics. While mAbs have undoubtedly improved treatment for many chronic diseases, including inflammatory diseases, they are typically expensive for health care systems and patients. Consequently, a...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2021-07-01
|
| Series: | Medicine Access @ Point of Care |
| Online Access: | https://doi.org/10.1177/23992026211027692 |